We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Nilemdo

News List

Daiichi Sankyo’s cholesterol-lowering drugs recommended for NHS use pharmatimes
April 30, 2021
The UK’s National Institute for Health and Care Excellence (NICE) has recommended Daiichi Sankyo’s cholesterol drugs Nilemdo and Nustendi for use on the NHS, benefitting around 70,000 adults in England with high cholesterol.
UK approval for Daiichi Sankyo’s cholesterol-lowering treatments pharmatimes
March 18, 2021
Daiichi Sankyo’s cholesterol-lowering drugs Nilemdo and Nustendi have been approved by the UK National Institute for Health and Care Excellence (NICE) for use on the NHS.
EC approves Nilemdo™ (bempedoic acid) for lowering cholesterol europeanpharmaceuticalreview
April 10, 2020
The European Commission has granted Esperion approval for Nilemdo, the company has sold commercialisation rights to Daiichi Sankyo.